3- 4 payment is to be made by PFIZER and (b) deducting therefrom the amount of any tax, duty, charge, commission, discount or other fee payable in respect of such conversion into, and remittance of, U.S. Dollars; provided, that in the event any...Royalty Agreement • December 20th, 1995 • Oncogene Science Inc • In vitro & in vivo diagnostic substances
2- 3 consummate the public sale or other disposition of the Registrable Securities subject to the rights of others with similar rights. The Company agrees to maintain such registration statement or post-effective amendment with respect to the...Registration Rights Agreement • December 20th, 1995 • Oncogene Science Inc • In vitro & in vivo diagnostic substances
1 EXHIBIT 10.19 OSI ROYALTY FREE LICENSE This AGREEMENT is entered into as of April 1, 1986 by and between PFIZER INC. ("PFIZER"), a Delaware corporation having an office at 235 East 42nd Street, New York, New York 10017, and ONCOGENE SCIENCE, INC....License • December 20th, 1995 • Oncogene Science Inc • In vitro & in vivo diagnostic substances • New York
BETWEENCollaborative Agreement • December 20th, 1995 • Oncogene Science Inc • In vitro & in vivo diagnostic substances • New York
1 EXHIBIT 10.20 PFIZER ROYALTY FREE LICENSE This AGREEMENT is entered into as of April 1, 1986 by and between PFIZER INC. ("PFIZER"), a Delaware corporation having an office at 235 East 42nd Street, New York, New York 10017, and ONCOGENE SCIENCE, INC....Pfizer Royalty Free License • December 20th, 1995 • Oncogene Science Inc • In vitro & in vivo diagnostic substances • New York
CIBA-GEIGY LIMITED BASLE, SWITZERLANDOncogene Science Inc • December 20th, 1995 • In vitro & in vivo diagnostic substances • New York
